You are here:- About .. Steering Committee

Steering Committee

The Steering committee is an independent group of HIV experts and is instrumental in helping achieve the aims and objectives of HIV in Europe.

The Co-Chairs

 Brian West

Board of Directors, European AIDS Treatment Group (EATG)

 

Brian West is on the Board of Directors of the EATG - a voluntary organisation which has more than 175 members from 47 countries in Europe. He also serves on the Steering committee of AIDS Action Europe, a pan-European NGO. Closer to home, he is a trustee/director on the board of Waverley Care, Scotland’s largest NGO provider of services for people living with HIV.

 


 Jürgen Rockstroh

 MD, Professor of Medicine and Head of the HIV Outpatient Clinic at the  University of Bonn, Germany

 


An active member of the HIV/AIDS treatment community, Dr Rockstroh was the Chairman of the German Clinical AIDS Working Group (KAAD) from 1998 to 2007. From 2007 to 2011, he was elected as the president of the German AIDS Society. From 2009, he has been a member of the executive committee of the European AIDS Clinical Society (EACS).


Members

Jordi Casabona

Scientific Director, Center for HIV/STI Epidemiological Studies of Catalonia (CEEISCAT)
  Jordi Casabona is a medical epidemiologist. President of the Fundació Sida i Societat and Associated Professor of Epidemiology and Preventive Medicine at the Autonomous University of Barcelona (UAB). He is the Principal Investigator of the European Union financed "HIV Community Based Testing Practices in Europe" project (COBATEST) and a member of the COHERE Executive Committee.  

Nikos Dedes

Past Chair of the Board of Directors
European AIDS Treatment Group (EATG), Greece

 

Nikos Dedes is past Chair of the Board of Directors at EATG, a voluntary organisation built on more than 90 members across 30 different European countries, founded in 1991. He is also founder of the NGO 'Synthesis', which aims to increase awareness, prevent and promote scientific research about HIV/AIDS in Greece. He is also Co-Chair of the HIV/AIDS Civil Society Forum.

Valerie Delpech

Epidemiologist, Public Health England
United Kingdom

  Valerie Delpech oversees the national surveillance of HIV based at Public Health England, London, United Kingdom. She provides expert advise on a number of national and international committees and expert groups in relation to HIV surveillance, prevention and policy development and led on the production of the European Centre for Disease Control (ECDC) evidence and guidance to increase HIV testing across Europe.

José Gatell

Head, Infectious Diseases & AIDS Units, Clinical Institute of Medicine & Dermatology, Hospital Clinic
Professor of Medicine, University of Barcelona, Spain

  Jose Gatell is Chair of "HIV in Spain 2009" and past President of the executive committee of the European AIDS Clinical Society. He served as the co-chair of the XIV International AIDS Conference, Barcelona, July 2002, and is a member of the Spanish Society Infectious Diseases and Clinical Microbiology (SEIMC), Catalan Society of Infectious Diseases and European Union AIDS Programme.

Brian Gazzard

Professor of Medicine, Imperial College School of Medicine
HIV Research Director, Chelsea & Westminster Hospital, UK

 

Brian Gazzard is the founding chairman of the British HIV Association (BHIVA) and sits on the Editorial Board of the BHIVA/EACS journal HIV Medicine.

 

Igor Karpov

Professor, Department of Infectious Disease
Belarus State Medical University

 

 

 

 

Jeff Lazarus

Professor of International Health Systems, University of Copenhagen
Denmark

  Jeff Lazarus is Chair of the Board of AFEW, on the board of the EASL International Liver Foundation, and Editor-in-Chief of Hepatology, Medicine and Policy. He previously worked at WHO and the Global Fund, and led the Health Systems Global secretariat.

 


Jens D. Lundgren

MD, Professor of Viral Diseases, University of Copenhagen; Director, CHIP, Copenhagen, Denmark.

  Professor Lundgren established CHIP, Centre for Health & Infectious Disease Research in 1994. Since, he has been actively involved in international research in the field of infectious diseases, viral infections and HIV in particular. Further, he co-chaired the HIV in Europe initiative from its conception in 2007 until 2014.

Mojca Matičič

University Medical Centre Ljubljana

  Mojca Matičič has been the Head of the Viral Hepatitis Unit at the Clinic for Infectious Diseases and Febrile Illnesses, and Head of the Outpatient STI Service at the University Medical Centre Ljubljana. She leads the multidisciplinary National Viral Hepatitis Expert Group of Slovenia and is an active member of the HIV/AIDS Committee at the Slovene Ministry of Health. She is a member of the European Association for the Study of the Liver (EASL), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and advisor at WHO HIV/STD/Viral Hepatitis sector. She is a senior clinical editor of the international medical journal Hepatology, Medicine and Policy (HMAP). 

   

Stefan Mauss

Center for HIV and Hepatogastroenterology

 

Stefan Mauss founded the Center for HIV and Hepatogastroenterology, an outpatient clinic and privately based research centre. His primary research interests are complications of antiviral therapy and their management in HIV, hepatitis B and hepatitis C.

  Ludmila Maistat

Alliance for Public Health, Ukraine
International Alliance Center for HIV, Hepatitis C and Drug Use

  Ludmila Maistat has been working in HIV/AIDS field for more than 10 years. Since 2012 she has been leading the all-Ukrainian advocacy campaigns and projects aimed at expanding access to hepC diagnostics and treatment with particular focus on co-infection with HIV and  key populations in Ukraine. She is actively involved in the hepC advocacy work in EECA region and internationally being part of the International  Hepatitis C Coalition and other advocacy groups, coordinates international HepC projects  of the Alliance Center for HIV, Hepatitis C and Drug Use.

   Tom Platteau

HIV/STI clinic of the Institute of Tropical Medicine in Antwerp
   Tom Platteau is mental health scientist and sexologist. He works at the HIV/STI clinic of the Institute of Tropical Medicine in Antwerp, Belgium. Since 2007, he coordinates projects on the development and implementation of novel HIV/STI testing using outreach and online strategies.

Stanislas Pol

Professor of Hepatology and Gastroenterology at Université Paris Descartes, Paris, France

 

Stanislas Pol is the Head of the Liver department at Cochin Hospital, Paris, France. His career includes a Hepatology and Gastroenterology residency, chief residency at the Necker-Enfants Malades University.



Anders Sönnerborg  

MD, PhD, Professor, Department of Medicine
Karolinska University Hospital, Sweden

 

Anders Sönnerborg is Professor of Infectious Diseases and Clinical Virology at Karolinska Institutet, Stockholm. He has been clinically and scientifically active in the field of HIV since 1983. He is director of the Swedish InfCare HIV cohort and of the Swedish Reference group for Antiviral Therapy. 

Nino Tsereteli

Executive Director of "Tanadgoma"
Georgia

  Nino Tsereteli has been working in the field of HIV/AID for more than 12 years. In 2000, together with the group of young professionals, she founded a Non-Governmental Organization “Center for Information and Counseling on Reproductive Health – Tanadgoma”, aiming at prevention of HIV and STIs and promoting reproductive health issues among Georgian population. In 2007 Ms. Tsereteli was appointed as Executive Director of “Tanadgoma”.

John de Wit

Professor, University of New South Wales
Director, Centre for Social Research in Health

  John de Wit (MSc, PhD) is professor and director of the Centre for Social Research in Health at the University of New South Wales, Sydney, and visiting professor in social psychology of health and sexuality at Utrecht University, The Netherlands. John has been undertaking and leading behavioral and social research regarding HIV, STI and sexual health for over 25 years, and his expertise and interest is especially with theory-informed research into the individual, social and structural factors that shape effective prevention, diagnosis and treatment.

Wim Zuilhof

Manager of the National HIV and STI prevention programs for MSM and ethnic minorities, STI Aids Netherlands 

  Wim Zuilhof works at STI Aids Netherlands as manager of the National HIV and STI prevention programs for MSM and ethnic minorities in the Netherlands. He is involved in HIV prevention policies and strategies since 1988. Among other things he initiated and coordinated the current joint online strategy for MSM in the Netherlands, a series of online behavioral surveys among MSM and HIV testing campaings for ethnic minorities and MSM.    
He contributed to the creation of the H-TEAM, a unique collaboration between all stakeholders involved in the prevention and care of HIV in Amsterdam, including key affected communities. In this consortium he coordinates  the work package on early testing and direct treatment of MSM.  
Observers
  Public Health England (PHE) 

Represented by Kevin Fenton

 

Kevin Fenton, M.D., Ph.D., FFPH, is the director of Health and Wellbeing 


 

WHO Regional Office for Europe, Communicable Diseases Unit

Represented by Martin Donoghoe

   

 

European Centre for Disease Prevention and Control  (ECDC)

Andrew Amato

 

 

 

Regional Support Team for Europe and Central Asia UNAIDS/ONUSIDA

Represented by Jean-Elie Malkin

 

Jean-Elie Malkin is Senior Adviser to Executive Director
Acting Director of the Regional Support Team for Europe and Central Asia UNAIDS/ONUSIDA.

 

European Monitoring Centre for Drugs and Drug Addiction, EMCDDA 

Represented by Lucas Wiessing

 

 

 

 

Hepatitis B & C Public Policy Association

Represented by  Angelos Hatzakis

 

Angelos Hatzakis is co-chair for Hepatitis B & C Public Policy Association

 


NEWS
 Late presentation of chronic viral hepatitis for medical care: a consensus definition
Monday, May 08, 2017

New publication! Late presentation of chronic viral hepatitis for medical care: a consensus definition. Read the full article here.

 
 Two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL
Tuesday, April 04, 2017

Don't miss out! Join a two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL. The course takes place on 28 and 29 September 2017. Read more here.

 
 Evaluation of the HepHIV 2017 Conference
Monday, April 03, 2017

The evaluation report from the HepHIV conference is now available. You can access it here.

 
 The HIV in Europe 2016 Annual Report is now available!
Monday, April 03, 2017

You can now read about our 2016 projects, activities and achievements in our annual report. Find it here.

 
 New report: The HIV in Europe initiative - the first 10 years
Tuesday, January 31, 2017

2017 marks 10 years of HIV in Europe - read about the 10 years of working with different stakeholders to promote earlier testing and care in our new report

 
 HepHIV 2017 Malta Conference
Tuesday, January 31, 2017

HepHIV 2017 Conference is now taking place in Malta (31 January - 2 February 2017). See full programme here. You can also follow news and updates on Twitter by following the conference hashtag #HepHIV2017

 

Copyright 2009 by HIV in Europe